Publication dates

Prostate Cancer Industry, February 2015 Market Reports from Top Publishers

You might be interested in: drug, cancer, cancer drug, medical equipment, nucleic acid testing, therapeutics, melanoma, hormone, plc, ultrasound, cancer therapeutics, lymphoma, magnetic resonance imaging, leukemia, oncology.


 
1-10 of about 200 reports for Prostate Cancer

Prostate Cancer Drug Pathway Analyzer 2015

Prostate Cancer Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

... Specifications3. Compare - you can overlay any pathways with each other and do a comparative analysisyou can interactively analyze any prostate cancer drug-pathway relationship by using up to four ...

Bavarian Nordic A/S (Symbol:BAVA) SWOT Analysis, Strategy, Revenues and Profits

Bavarian Nordic A/S (Symbol:BAVA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Such as smallpox, prostate cancer, anthrax, breast cancer, marburg and ebola infections, among others. The company also develops viral vaccines for research, clinical and commercial applications. It operates ...

Bio-Path Holdings, Inc. (Symbol:BPTH) SWOT Analysis, Strategy, Revenues and Profits

Bio-Path Holdings, Inc. (Symbol:BPTH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Its products are used in the treatment of lymphoma, chronic myelogenous leukemia, acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndrome, breast cancer, colon cancer, prostate ...

GeneNews Limited (Symbol:GEN) SWOT Analysis, Strategy, Revenues and Profits

GeneNews Limited (Symbol:GEN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Blood transcriptome analysis and data mining. The company's diagnostic areas include colon cancer, lung cancer, prostate cancer and breast cancer. Its products are available in canada, malaysia, china ...

Virax Holdings Limited (Symbol:VHL) SWOT Analysis, Strategy, Revenues and Profits

Virax Holdings Limited (Symbol:VHL) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Under clinical development include skin cancer immunotherapeutic, vir201, vir501, and therapeutic hbv vaccine. The company's vir201 vaccine is used a hiv vaccine; and vir501 is a prostate cancer vaccine ...

Merrion Pharmaceuticals Plc (Symbol:3MP) SWOT Analysis, Strategy, Revenues and Profits

Merrion Pharmaceuticals Plc (Symbol:3MP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Almero, acyline and mer-102. Its products find application in the treatment of diseases such as bone metastases, breast cancer, osteoporosis, prostate cancer and deep vein thrombosis. The company has ...

Oneness Biotech Co., Ltd. (Symbol:4743) SWOT Analysis, Strategy, Revenues and Profits

Oneness Biotech Co., Ltd. (Symbol:4743) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... For the treatment of diabetic foot ulcer injury, anti-liver cancer, acnes, liver cancer, prostate cancer, lung cancer and non-proliferation of estrogen-dependent breast cancer. The company focuses on the technology ...

Endocyte, Inc. (ECYT) - Financial and Strategic SWOT Analysis Review

Endocyte, Inc. (ECYT) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Are used to treat solid tumors; folcepri used in treatment of folate receptor positive tumors; ec1169 used to treat prostate cancer, ec0652 to treat prostate tumors; ec1669 used in the treatment ...

GenSpera, Inc. (GNSZ) - Financial and Strategic SWOT Analysis Review

GenSpera, Inc. (GNSZ) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... cancer. Genspera's technology platform supports the development of drugs targeted at different cancers, and other applications such as imaging. The company has patents for the development of tumor ...

MetaStat, Inc. (MTST) - Financial and Strategic SWOT Analysis Review

MetaStat, Inc. (MTST) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Of metastasis in adenocarcinoma of the lung. Metastat also offers menacalc prostate, a diagnostic for prostate cancer; and menabloc, a platform technology that develops therapies that can preemptively reduce ...

About 2 000 reports for Prostate Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the UK Forecast

  • January 2014
    28 pages
  • Prostate Cancer  

    Cancer  

  • United Kingdom  

View report >

4 Companies for Prostate Cancer

Read our Company Profiles

Johnson and Johnson

United States

Novartis Inc.

Switzerland

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.